Essbio Balance Sheet Health
Financial Health criteria checks 2/6
Essbio has a total shareholder equity of CLP374.4B and total debt of CLP594.6B, which brings its debt-to-equity ratio to 158.8%. Its total assets and total liabilities are CLP1,072.1B and CLP697.8B respectively. Essbio's EBIT is CLP73.0B making its interest coverage ratio 5.2. It has cash and short-term investments of CLP14.3B.
Key information
158.8%
Debt to equity ratio
CL$594.58b
Debt
| Interest coverage ratio | 5.2x |
| Cash | CL$14.33b |
| Equity | CL$374.36b |
| Total liabilities | CL$697.77b |
| Total assets | CL$1.07t |
Recent financial health updates
Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
May 30
Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden
Feb 15Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
Nov 17Recent updates
Investors Appear Satisfied With Essbio S.A.'s (SNSE:ESSBIO-C) Prospects As Shares Rocket 48%
May 21We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings
Sep 15Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
May 30A Look At The Intrinsic Value Of Essbio S.A. (SNSE:ESSBIO-C)
Mar 29Should You Be Impressed By Essbio's (SNSE:ESSBIO-C) Returns on Capital?
Mar 09Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden
Feb 15Should Essbio S.A. (SNSE:ESSBIO-C) Focus On Improving This Fundamental Metric?
Jan 04
Has Essbio (SNSE:ESSBIO-C) Got What It Takes To Become A Multi-Bagger?
Dec 08Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
Nov 17Financial Position Analysis
Short Term Liabilities: ESSBIO-C's short term assets (CLP67.9B) exceed its short term liabilities (CLP64.8B).
Long Term Liabilities: ESSBIO-C's short term assets (CLP67.9B) do not cover its long term liabilities (CLP632.9B).
Debt to Equity History and Analysis
Debt Level: ESSBIO-C's net debt to equity ratio (155%) is considered high.
Reducing Debt: ESSBIO-C's debt to equity ratio has increased from 106.8% to 158.8% over the past 5 years.
Debt Coverage: ESSBIO-C's debt is not well covered by operating cash flow (17.2%).
Interest Coverage: ESSBIO-C's interest payments on its debt are well covered by EBIT (5.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 16:23 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Essbio S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|